Clinical Trials Support Services Market Outlook to 2030: Top Manufacturer Analysis, Industry Overview and Forecast Repor

The global clinical trials support services market was estimated at USD 19.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030.

Clinical Trials Support Services Industry Overview

The global clinical trials support services market was estimated at USD 19.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.5% from 2022 to 2030.

The global market is projected to expand rapidly due to the rising demand for trials in emerging economies, rising RD investment, and an increasing number of contract research organizations (CROs). The pharmaceutical firms’ (RD) venture has been steadily increasing every year, largely due to patent expirations. An ordinary patent terminates after 20 years; in the pharmaceutical area, there is an arrangement that provides for the entry of a generic version of the medication into the market following a time of 10 years. Thus, firms are boosting their RD interests to speed the advancement of drugs, subsequently extending the whole market.

Clinical trials support services are quite useful in the event of a drug, assay design, and clinical testing. It also covers tasks such as strengthening clinical test locations, securing and storing research medicines, drug dosage calculation, and kit handling. Preclinical groundwork and research are provided by clinical test support services, which include clinical test site assistance, obtaining and storing study drugs, blinding of study drugs, patient recruiting, coordination, and reconciliation of returned medications.

Gather more insights about the market drivers, restraints and growth of the Global Clinical Trials Support Services Market

The clinical trial sector underwent significant changes in 2021. With the introduction of COVID-19 vaccines, numerous clinical trials that had been halted due to the pandemic were re-initiated. In the first quarter of 2021, around 44% more clinical trials commenced compared to the first quarter of 2020. Although in-person clinical trials were once again viable, adoption of new technologies remained high, with 74% of sponsors adopting remote monitoring and 77% of sites using eRegulatory software.

Many software tools for data management are referred to as “Clinical Data Management” (CDM) systems. Multicentric trials require CDM systems to handle massive volumes of data. The majority of CDM systems utilized by pharmaceutical companies are commercial, but there are a few free-source tools accessible as well. Oracle Clinical, Clintrial, Oracle Clinical, Macro, RAVE, and eClinical Suite are common CDM tools. Maintaining an audit record of data management actions is important in regulatory submission studies. These CDM tools help ensure the audit trail and manage discrepancies. The CDM activities include data collection, CRF tracking, CRF annotation, database design, data entry, medical coding, data validation, discrepancy management, and database lock.

Browse through Grand View Research's Medical Devices Industry Related Reports

  • Clinical Trial Biorepository Archiving Solutions Market - The global clinical trial biorepository archiving solutions market size was valued at USD 3.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030.
  • Abdominal Pads Market - The global abdominal pads market size was valued at USD 967.9 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2023 to 2030.

Clinical Trials Support Services Industry Segmentation

Grand View Research has segmented the clinical trials support services market based on service type, phase, sponsor, and region:

Clinical Trials Support Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinical trial site management
  • Patient recruitment management
    • Patient recruitment registry
    • Patient retention
    • Others
  • Data management
  • Administrative staff
  • IRB
  • Others

Clinical Trials Support Services Phase Outlook (Revenue, USD Million, 2018 - 2030)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Clinical Trials Support Services Sponsor Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical Biopharmaceutical companies
  • Medical Devices
  • Others

Clinical Trials Support Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA (Middle East Africa)

Key Companies profiled:

Some prominent players in the global Clinical Trials Support Services Industry include

  • Charles River Laboratories Inc.
  • Eurofins Scientific
  • IQVIA
  • Syneos Health Inc.,
  • The Pharmaceutical Product Development LLC
  • Icon PLC
  • WuXi AppTec
  • LabCorp
  • Alcura
  • Parexel International

Order a free sample PDF of the Clinical Trials Support Services Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter


rajeshsinha

216 Blog posts

Comments